Inflammation as a Therapeutic Target To Improve Vascular Function in Kidney Disease

被引：4
|
作者：
Walther, Carl P. [1 ]
Navaneethan, Sankar D. [1 ,2 ]
机构：
[1] Baylor Coll Med, Dept Med, Selzman Inst Kidney Hlth, Nephrol Sect, Houston, TX 77030 USA
[2] Michael E DeBakey VA Med Ctr, Nephrol Sect, Houston, TX USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2017年 / 28卷 / 03期
基金：
美国国家卫生研究院;
关键词：
INHIBITION; ARTHRITIS;
D O I：
10.1681/ASN.2016111173
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：723 / 725
页数：3
相关论文
共 50 条
  • [1] Vascular Function and Vascular Inflammation in Polycystic Kidney Disease
    Heffernan, Kevin S.
    Rudym, D.
    Kuvin, Jeffrey T.
    Karas, Richard H.
    Miskulin, D.
    Perrone, R.
    Sarnak, M.
    Menon, V.
    CIRCULATION, 2009, 120 (18) : S1078 - S1078
  • [2] Innate and Adaptive Inflammation as a Therapeutic Target in Vascular Disease
    Tousoulis, Dimitris
    Psarros, Costas
    Demosthenous, Michael
    Patel, Rikhil
    Antoniades, Charalambos
    Stefanadis, Christodoulos
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (23) : 2491 - 2502
  • [3] Vascular inflammation as a therapeutic target for prevention of cardiovascular disease.
    Clark L.T.
    Current Atherosclerosis Reports, 2002, 4 (2) : 77 - 81
  • [4] Hepcidin as a therapeutic target for anemia and inflammation associated with chronic kidney disease
    Malyszko, Jolanta
    Malyszko, Jacek S.
    Matuszkiewicz-Rowinska, Joanna
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2019, 23 (05) : 407 - 421
  • [5] Rosiglitazone does not improve vascular function in subjects with chronic kidney disease
    Chan, Doris T.
    Watts, Gerald F.
    Irish, Ashley B.
    Dogra, Gursharan K.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (11) : 3543 - 3549
  • [6] Calprotectin is a contributor to and potential therapeutic target for vascular calcification in chronic kidney disease
    Amaya-Garrido, Ana
    Brunet, Manon
    Buffin-Meyer, Benedicte
    Piedrafita, Alexis
    Grzesiak, Lucile
    Agbegbo, Ezechiel
    Del Bello, Arnaud
    Ferrandiz, Ines
    Ardeleanu, Serban
    Bermudez-Lopez, Marcelino
    Fedou, Camille
    Camus, Mylene
    Burlet-Schiltz, Odile
    Massines, Jean
    Buleon, Marie
    Feuillet, Guylene
    Alves, Melinda
    Neau, Eric
    Casemayou, Audrey
    Breuil, Benjamin
    Saulnier-Blache, Jean-Sebastien
    Denis, Colette
    Voelkl, Jakob
    Glorieux, Griet
    Hobson, Sam
    Arefin, Samsul
    Rahman, Awahan
    Kublickiene, Karolina
    Stenvinkel, Peter
    Bascands, Jean-Loup
    Faguer, Stanislas
    Valdivielso, Jose M.
    Schanstra, Joost P.
    Klein, Julie
    SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (712)
  • [7] INFLAMMATION AS A THERAPEUTIC TARGET IN CARDIOVASCULAR DISEASE
    Ritchie, R.
    CARDIOLOGY, 2015, 132 : 32 - 32
  • [8] Senolytics, Dasatinib Plus Quercetin, Improve Kidney Function and Reduce Inflammation in Murine Diabetic Kidney Disease
    Bian, Xiaohui
    Snow, Zachary K.
    Smith, Anastasia L.
    Skaff, Caroline J.
    Elhusseiny, Khaled Mosaad
    Zhu, Yi
    Tchkonia, Tamara
    Kim, Seo Rin
    Kirkland, James L.
    Lerman, Lilach O.
    Hickson, LaTonya J.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 99 - 99
  • [9] The role of inflammation in autoimmune disease: a therapeutic target
    Xiang, Yu
    Zhang, Mingxue
    Jiang, Die
    Su, Qian
    Shi, Jianyou
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [10] Gut Microbiota in Vascular Disease: Therapeutic Target?
    Anbazhagan, A. N.
    Priyamvada, S.
    Priyadarshini, M.
    CURRENT VASCULAR PHARMACOLOGY, 2017, 15 (04) : 291 - 295
12345